240 related articles for article (PubMed ID: 19013006)
1. Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT.
Suzuki M; Sugimoto A; Harashima A; Otani T; Yamamoto M; Nakamura S; Yamasaki F; Nishiyama M; Okazaki Y; Kibata M
Exp Hematol; 2009 Jan; 37(1):92-100. PubMed ID: 19013006
[TBL] [Abstract][Full Text] [Related]
2. IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.
Nakamura S; Suzuki M; Sugimoto A; Tsuji-Takayama K; Yamamoto M; Otani T; Inoue T; Harashima A; Okochi A; Motoda R; Yamasaki F; Orita K; Kibata M
Exp Hematol; 2007 Feb; 35(2):287-96. PubMed ID: 17258077
[TBL] [Abstract][Full Text] [Related]
3. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
[TBL] [Abstract][Full Text] [Related]
4. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
5. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
6. Cell-in-cell structures formed between human cancer cell lines and the cytotoxic regulatory T-cell line HOZOT.
Takeuchi M; Inoue T; Otani T; Yamasaki F; Nakamura S; Kibata M
J Mol Cell Biol; 2010 Jun; 2(3):139-51. PubMed ID: 20348186
[TBL] [Abstract][Full Text] [Related]
7. Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells.
Li L; Li SP; Min J; Zheng L
Immunol Lett; 2007 Nov; 114(1):38-45. PubMed ID: 17945351
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.
Trzonkowski P; Szmit E; Myśliwska J; Dobyszuk A; Myśliwski A
Clin Immunol; 2004 Sep; 112(3):258-67. PubMed ID: 15308119
[TBL] [Abstract][Full Text] [Related]
9. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
[TBL] [Abstract][Full Text] [Related]
10. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.
Wu J; Yi S; Ouyang L; Jimenez E; Simond D; Wang W; Wang Y; Hawthorne WJ; O'Connell PJ
Transplantation; 2008 Jun; 85(12):1841-8. PubMed ID: 18580479
[TBL] [Abstract][Full Text] [Related]
11. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
[TBL] [Abstract][Full Text] [Related]
12. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
Fenoglio D; Ferrera F; Fravega M; Balestra P; Battaglia F; Proietti M; Andrei C; Olive D; Antonio LC; Indiveri F; Filaci G
Hum Immunol; 2008 Nov; 69(11):745-50. PubMed ID: 18832002
[TBL] [Abstract][Full Text] [Related]
13. Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls.
Zhang L; Jarvis LB; Baek HJ; Gaston JS
Ann Rheum Dis; 2009 Aug; 68(8):1345-51. PubMed ID: 18647857
[TBL] [Abstract][Full Text] [Related]
14. Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8(+) T cells.
Ring S; Karakhanova S; Johnson T; Enk AH; Mahnke K
J Allergy Clin Immunol; 2010 Jan; 125(1):237-46.e1-7. PubMed ID: 20109751
[TBL] [Abstract][Full Text] [Related]
15. Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins.
Inoue T; Tashiro Y; Takeuchi M; Otani T; Tsuji-Takayama K; Okochi A; Mukae Y; Koreishi M; Yamasaki F; Kumon H; Nakamura S; Kibata M; Kondo E
Int J Oncol; 2011 May; 38(5):1299-306. PubMed ID: 21373756
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
17. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
[TBL] [Abstract][Full Text] [Related]
18. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance.
Dubois B; Joubert G; Gomez de Agüero M; Gouanvic M; Goubier A; Kaiserlian D
Gastroenterology; 2009 Sep; 137(3):1019-28. PubMed ID: 19345221
[TBL] [Abstract][Full Text] [Related]
19. Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells.
Lagaraine C; Lemoine R; Baron C; Nivet H; Velge-Roussel F; Lebranchu Y
J Leukoc Biol; 2008 Oct; 84(4):1057-64. PubMed ID: 18611986
[TBL] [Abstract][Full Text] [Related]
20. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
